Publications
April 2025
CJEU revisits Art. 3(a) and 3(c) of the SPC Regulation – Teva BV u.a. vs Merck Sharp & Dohme Corp
Authors:
Dr. Michael Best, Dr. Oliver Ladendorf,
Dr. Jonas Thelemann
January 2021
Practical consequences of the new Rules of Procedure of the Boards of Appeal
Authors:
Dr. Evy Corbanie, Dr. Stefan Weist,
Dr. Marc Gerauer
October 2020
Patent Infringement in 3D Printing
Technology and Liability of the Managing Director
Author:
Dr. Marc Gerauer
July 2018
Patentverletzung im Hinblick auf den 3D-Druck und Geschäftsführerhaftung
Author:
Dr. Marc Gerauer
June 2018
May 2017
Patentability of products obtained by essentially biological processes in Europe
Authors:
Dr. Oliver Ladendorf, Dr. Evy Corbanie
April 2016
What is the relevant date of marketing authorization to determine the term of an SPC?
Authors:
Dr. Oliver Ladendorf, Dr. Alexander Kleefen
April 2016
May a part of a fusion protein be considered an "active ingredient"? Yes, says the ECJ in Forsgre
Authors:
Dr. Oliver Ladendorf, Dr. Alexander Kleefen
March 2016
Eli Lilly vs. HGS (C-493/12):
The UK High Court clarifies the ECJ's enigmatic decision
Authors:
Dr. Oliver Ladendorf, Dr. Alexander Kleefen
Contact
KRAUS & LEDERER PartGmbB
Patentanwälte | European Patent and Trademark Attorneys
Thomas-Wimmer-Ring 15
80539 Munich
Germany
T +49 89 29060 - 0
F +49 89 29060 - 111
www.kraus-lederer.de
Proud to be honoured
We have received awards from renowned national and international handbooks, magazines, newspapers and international professional journals and are proud when good work is recognized.
News
Juve Patent recommends KRAUS & LEDERER
We are delighted to have been recommended in the current Patent Germany Ranking 2025 …
Table football tournament of German patent attorneys
A lovely evening for a good cause – and a great opportunity for networking! …